Hong Kong Med J 2009;15:94-9 | Number 2, April 2009
Should young age be a contra-indication to breast conservation treatment in Chinese women? Twelve-year experience from a public cancer centre in Hong Kong
TK Yau, CW Choi, Henry Sze, Inda S Soong, Anne WM Lee
Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong Kong
OBJECTIVE. It has been proposed that young women should not be treated by breast conservation treatment because of a higher risk of local recurrences and worse survival. We therefore examined whether breast conservation treatment in young Chinese women yielded inferior clinical outcomes compared to modified radical mastectomy.
DESIGN. Retrospective study.
SETTING. Clinical oncology department in a public hospital in Hong Kong.
PATIENTS. A total of 258 Chinese women with invasive breast cancer, aged below 40 years, and referred between January 1994 and July 2006.
RESULTS. A total of 124 (48%) and 134 (52%) patients were treated by breast conservation treatment and modified radical mastectomy, respectively. Mastectomy patients tended to have larger primary tumours (P
CONCLUSION. Breast conservation treatment is a reasonable option for many suitably selected young Chinese women.
Key words: Breast neoplasms; Disease-free survival; Mastectomy; Middle aged; Neoplasm recurrence, local
View this abstract indexed in MEDLINE: